Dyne Therapeutics, Inc. (DYN) vs Tarsus Pharmaceuticals, Inc. (TARS)
Dyne Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. is the larger, with a market value of $3.6B against $3.1B — 1.1× the size. Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −7.67%) and the lower return on invested capital (−1,956.3% vs 0.00%). Across the 14 metrics below, Tarsus Pharmaceuticals, Inc. leads on 9 and Dyne Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | DYN | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.28% | 65.16% |
| Operating margin | 0.00% | (8.00%) | 0.00% |
| Net margin | 0.00% | (7.67%) | 0.00% |
| Free cash flow margin | 0.00% | 9.24% | 0.00% |
| Return on equity | (81.57%) | (13.68%) | (57.72%) |
| Return on assets | (60.29%) | (8.40%) | (49.22%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack